Updated:
Constellation Brands reported fiscal second-quarter 2027 results above Wall Street estimates on October 6, but the earnings beat did not resolve investor questions about consumer demand. The beverage company posted comparable earnings of $3.74 a share on revenue of $2.63 billion, compared with analyst expectations of $3.61 a share and $2.54 billion in sales.
Management kept its full-year forecast unchanged. It said results could reach the upper end of its earnings range if September trends persist, while beer depletions—the company’s measure of sales from distributors to retailers—remained slightly negative for the quarter. The contrast between stronger reported shipments and softer underlying sales leaves volume trends and distributor inventories among the next results investors will watch.
Sales and earnings topped expectations
The company’s adjusted earnings per share exceeded the cited consensus estimate by 3.6%, while revenue came in about 3.5% above forecast. Citi’s post-results assessment also attributed the earnings beat to stronger beer shipments and margins, along with higher operating income from wine and spirits.
The results arrived after a difficult period for the stock: the company’s shares had been trading near the bottom of their 52-week range. Trading was mixed around the report. They rose during October 7’s session after an initial post-results decline, underscoring that investors were weighing the quarterly beat against questions about the outlook.
Depletions show the demand challenge
Constellation reported beer depletions down 0.6% in the quarter, below the consensus expectation of a 0.1% increase cited by Citi. The split by sales channel was uneven: off-premise depletions fell 1.5%, while on-premise depletions increased 6.6%. The company attributed some of the comparisons to calendar timing, including an extra day and the placement of Labor Day.
Management said September depletions were moving in a more favorable direction. That update offers a potential sign of stabilization, but a single month does not establish a sustained recovery. The full-year outlook remains conditional on whether the improvement continues.
Reported shipments also need to be distinguished from consumer demand. A contemporaneous earnings analysis cited a Bank of America analyst’s estimate that Constellation shipped about eight million cases ahead of depletions in the first half, rebuilding distributor inventory. Management said distributor days on hand remained below the long-term average; whether later shipments will slow as inventories normalize remains an open question.
Guidance unchanged as margins and marketing remain in focus
Constellation maintained its fiscal 2027 comparable earnings-per-share range of $11.20 to $11.90. The company also retained its beer net-sales outlook of a decline of 1% to growth of 1%, and its full-year beer operating-margin range of 37% to 38%. Management indicated that achieving the high end of the earnings range would depend on September’s more positive trends continuing.
The company pointed to brand performance and marketing as part of its response to the softer demand backdrop. Executives described Constellation as the leading dollar-share gainer in beverage alcohol and said Pacifico had become a top-10 beer brand. They also reported growth across Pacifico, Victoria and Mi CAMPO, while saying Corona and Modelo were stabilizing. Those management assessments do not remove the need to track reported depletion data in coming quarters.
Buybacks and SpikedAde deal add to the picture
Capital allocation continued alongside the operating challenges. Constellation had repurchased $530 million of its shares year to date, with $2.5 billion remaining under an authorization that runs through fiscal 2028. The pace of future repurchases will be one measure of how the company balances returning cash to shareholders with other priorities.
The company also agreed to acquire SpikedAde, a spirit-based ready-to-drink brand, for $75 million at closing, with up to $278 million in contingent payments. The reported terms distinguish the upfront payment from the additional potential consideration; the available reporting did not detail the conditions governing those contingent payments.
What investors will watch next
The next scheduled financial checkpoint is Constellation’s fiscal third-quarter report, tentatively expected on January 7, 2027. The earnings analysis cited consensus estimates of $2.82 a share and $2.22 billion in revenue, though those forecasts may change before the release.
Before then, the main indicators will include monthly sales trends for Modelo and Corona, whether September’s improvement holds, and how shipments compare with depletions as distributor inventories adjust. The next report will also test whether the unchanged annual earnings outlook remains achievable. The company’s latest results beat estimates, but the persistence of consumer demand and the quality of sales growth are still unresolved.
